Category: Federal Forum Posters
Purpose: Clinical trials have shown proton pump inhibitor (PPI) therapy as being overprescribed, with safety risks related to long-term use. This project was designed to determine the frequency of new outpatient PPI prescriptions following hospital discharge from the VA Healthcare System, and if appropriate follow-up is being conducted in an ambulatory setting. One complication with long term PPI use is increase in clostridium difficile infections, and incidence of these infections will be collected as well.
Methods: A retrospective chart review will be performed on those Veterans discharged from general medicine teams July 2017 to December 2017. Patient records will be reviewed for 6-months post-discharge to collect demographic information, PPI use and indication, frequency of provider visits or phone calls, and incidence of clostridium difficile infection. New PPI prescriptions at discharge from internal medicine service will be recorded along with indication. Electronic chart notes and outpatient medication history will be followed throughout the pre-specified 3 and 6-month intervals post-discharge. Patient’s with an active outpatient medication prescription of acid suppression therapy (PPI/H2RA) written by a VA or non-VA provider prior to admission and, Veterans receiving follow-up from a non-VA provider will be excluded from data collection. Incidence of clostridium difficile will be defined by ICD-10 code diagnosis and CPRS electronic note review throughout the pre-specified 3 and 6-month intervals post-discharge.
Results: Not applicable
Conclusion: Not applicable
Ryan Chan– Pharmacy Resident, Portland VA, Portland, OR